Methods of treating skin disorders using an IL-31RA antagonist

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Binds antigen or epitope whose amino acid sequence is...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C424S085200, C424S178100, C424S135100

Reexamination Certificate

active

07871618

ABSTRACT:
The present invention relates to methods of treating patients suffering from Contact dermatitis, Drug induced delayed type cutaneous allergic reactions, Toxic epidermal necrolysis, Cutaneous T cell Lymphoma, Bullous pemphigoid, Alopecia aereata, Vitiligo, Acne Rosacea, Prurigo nodularis, Scleroderma, Herpes simplex virus, or combination by administering an IL-31RA antagonist.

REFERENCES:
patent: 7064186 (2006-06-01), Sprecher et al.
patent: 2003/0215838 (2003-11-01), Sprecher et al.
patent: 2003/0224487 (2003-12-01), Sprecher et al.
patent: 2004/0142422 (2004-07-01), Sprecher et al.
patent: 2004/0152161 (2004-08-01), Cosman et al.
patent: 00/75314 (2000-12-01), None
patent: 02/00690 (2002-01-01), None
patent: WO 0200721 (2002-01-01), None
patent: 02/29060 (2002-04-01), None
patent: 02/077230 (2002-10-01), None
patent: 03/072740 (2003-09-01), None
patent: 2004/003140 (2004-01-01), None
Definition of “lichenification” in Stedman's Medical Dictionary, 27th Ed. (2000 Lippincott Williams & Wilkins).
Aioi, A. et al.,Br J. Dermatol 144(1):12-18, 2001.
Akdis, C.A., et al.,J. Invest. Dermatol. 113(4) 628-34, 1999.
Aleksza, M., et al.,Br. J. Dermatol. 147(6):1135-41, 2002.
Antunez, C., et al.,Clin. Exp. Allergy 34(4) 559-66, 2004.
Asadullah, K. et al.,Arch. Dermatol 138(9):1189-96, 2002.
Askenase, P.W.,Chem. Immunol. 78:112-23, 2000.
Barnes, K.C., et al.,Genomics 37(1):41-50, 1996.
Berger, C.L., et al.,Blood 105(4):1640-7, 2005.
Bilsborough, J. et al.,J. Allergy Clin. Immunol. 117(2):418-25, 2006.
Bonecchi, R., et al.,J. Exp. Med. 187(1):129-34, 1998.
Dillon S.R., et al.,Nat. Immunol. 5(7):752-60, 2004.
Dillon, S.R., et al.,Nat. Immunol. 6(1):14, 2005.
Diveu, C., et al.,Eur. Cytokine Netw. 15(4):291-302, 2004.
Diveu, C., et al.,J. Biol. Chem. 278(50):49850, 2003.
Dreuw, A., et al.,Immunobiology 210(6-8), 454, 2005.
Dreuw, A., et al., Keystone Symposia “Cytokines, Disease and Therapeutic Intervention,” Feb. 12-17, 2005.
Dreuw, A., et al.,J. Biol. Chem. 279(34):36112-20, 2004.
Fang, D., et al.,Nat. Immunol. 3(3):281-7, 2002.
Ghilardi, N. et al.,J. Biol. Chem. 277(19):16831, 2002.
Gutermuth, J. et al.,Int. Arch. Allergy Immunol. 135(3):262-76, 2004.
Hashimoto, Y., et al.,Life Sci. 76(7):783-94, 2004.
Hashimoto, Y., et al.,J. Dermatol. Sci. 35(2):143-50, 2004.
Hermanns, H.M., et al.,Experimental Dermatology 15(N3):219-20, 2006.
Hijnen, D., et al.,J. Allergy Clin. Immunol. 113(2):334-40, 2004.
Hwang, S.T.,Adv. Dermatol. 17:211-41, 2001.
Leung, D.Y., et al.,Lancet 361(9352): 151-60, 2003.
Lin, L., et al.,J. Med. Dent. Sci. 50(1):27-33, 2003.
Nagao, M., et al.,J. Allergy Clin. Immunol. 15(2):s272, 2005.
Matsuda, H., et al.,Int. Immunol. 9(3):461-6, 1997.
Matsushima, H., et al.,J. Dermatol. Sci. 32(3):223-30, 2003.
Parrish-Novak, J.E., et al., Interleukin 31 is a novel four-helical-bundle cytokine that signals through a heterodimeric receptor complex expressed in epithelial cells of lung and skin, (1023) Annual Meeting of the American Society of Human Genetics, 2003..
Robert, C., et al.,N. Engl. J. Med. 341(24):1817-28, 1999.
Shimada, Y., et al.,J. Dermatol. Sci. 34(3):201-8, 2004.
Sonkoly, E., et al.,J. Allergy Clin. Immunol. 117(2):411-7, 2006.
Song, T., et al.,J. Allergy Clin. Immunol. 15(2):s100, 2005.
Takano, N., et al.,Eur. J. Pharmacol. 495(2-3):159-65, 2004.
Takano, N., et al.,Eur. J. Pharmacol. 471(3):223-8, 2003.
Takaoka, A., et al.,Exp. Dermatol. 15(3):161-7, 2006.
Takaoka, A.,Eur. J. Pharmacol. PMID:15925362, 2005.
Vestergaard, C., et al.,J. Invest. Dermatol. 115(4):640-6, 2000.
GenBank Accession No. AI123586, 1997.
Gen Bank Accession No. AI799583, 1997.
Harlow et al., Ed. Antibodies, A Laboratory manual. Cold Spring Harbor Press. 1998, pp. 23-26.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Methods of treating skin disorders using an IL-31RA antagonist does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of treating skin disorders using an IL-31RA antagonist, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treating skin disorders using an IL-31RA antagonist will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2737191

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.